| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/24/2008 | US7390793 Have fixed, preselected hydrodynamic diameters and are formed from basic or acidic amphiphilic compounds; compound E5564 and derivatives |
| 06/24/2008 | US7390791 Prodrugs of phosphonate nucleotide analogues |
| 06/24/2008 | US7390787 Comprising 8 to 25 amino acids and containing the formula: RXZXXZXB wherein Z is proline or valine; X is a hydrophobic residue; and B is a basic amino acid. |
| 06/24/2008 | US7390783 Charged phospholipid compositions and methods for their use |
| 06/24/2008 | US7390668 Halogenated xanthan compound |
| 06/24/2008 | US7390658 Lymphoid dendritic cells generated from hematopoietic stem cells which encode viricidal and antitumor agents for preventing tumor metastasis and viral infection; immunotherapy |
| 06/24/2008 | US7390625 Apoptosis-associated protein and use thereof |
| 06/24/2008 | US7390519 Probiotic Lactobacillus salivarius strains |
| 06/24/2008 | US7390487 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
| 06/22/2008 | CA2615637A1 Prevention of biofilm formation using pegylated blood products |
| 06/19/2008 | WO2008074031A1 Compositions and methods for treating infectious bronchitis |
| 06/19/2008 | WO2008074028A1 Methods for treating and reducing the incidence of newcastle disease |
| 06/19/2008 | WO2008073961A2 Compounds and methods for modulating the silencing of a polynucleotide of interest |
| 06/19/2008 | WO2008073891A2 Salmonella vaccine in poultry |
| 06/19/2008 | WO2008073863A2 Preparation and utility of substituted allylamines |
| 06/19/2008 | WO2008072726A1 1-phenyl 1-thio-d-glucitol derivative |
| 06/19/2008 | WO2008072682A1 Imidazo[1,2-b]pyridazine derivative |
| 06/19/2008 | WO2008072371A1 Preparation for sterilization or disinfection of tissue |
| 06/19/2008 | WO2008072032A1 Transdermal delivery systems of beta-lactam antibiotics |
| 06/19/2008 | WO2008071964A1 Naphthyridine bactericides |
| 06/19/2008 | WO2008071962A1 Pteridines and pyrimidinopyridines as antibacterial agents |
| 06/19/2008 | WO2008071961A1 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents |
| 06/19/2008 | WO2008071931A1 Piperidine derivative used for treating chemokine receptor 5 mediated diseases |
| 06/19/2008 | WO2008071927A1 Piperidine derivative used for treating chemokine receptor 5 mediated diseases |
| 06/19/2008 | WO2008071416A1 Morin, a new inhibitor of microbial hyaluronate lyase |
| 06/19/2008 | WO2008071359A1 Substituted aminofuranones and their use |
| 06/19/2008 | WO2008071197A1 Methods for treating cystic fibrosis or pneumonia with bacterial infection via pulmonary administration of fosfomycin |
| 06/19/2008 | WO2008071075A1 A process for preparation of extract of broussonetia papyritera and the use thereof in manufacture of a medicament |
| 06/19/2008 | WO2008070982A1 Archaeal polar lipid aggregates for administration to animals |
| 06/19/2008 | WO2008053219A3 Composition for the treatment of gastrointestinal diseases |
| 06/19/2008 | WO2008049974A8 Peptide vaccine for influenza virus |
| 06/19/2008 | WO2008045852A3 Purification of streptococcus pneumoniae type 3 polysaccharides |
| 06/19/2008 | WO2008043570A8 Interferon type i supporting compounds |
| 06/19/2008 | WO2008043424A3 Composition to treat or prevent gastrointestinal infection |
| 06/19/2008 | WO2008009894A3 Use of imino sugars in immunotherapy |
| 06/19/2008 | WO2007146968A3 Single-chain multivalent binding proteins with effector function |
| 06/19/2008 | WO2007111866A3 Combinations of hcv protease inhibitor(s) and cyp3a4 inhibitor(s), and methods of treatment related thereto |
| 06/19/2008 | WO2007099302A3 Methods of maintaining oral health in animals using morpholine derivatives |
| 06/19/2008 | WO2007087461A3 Use of gallium to treat biofilm-associated infectons |
| 06/19/2008 | US20080146803 Antibiotics containing borinic acid complexes and methods of use |
| 06/19/2008 | US20080146660 Androgen receptor antagonists; certain cancers such as colon, skin and prostate cancer, baldness, hirsutism, behavioral disorders, acne, and inhibition of spermatogenesis if so desired |
| 06/19/2008 | US20080146639 Reducing the incidence of fibrosis by the co-administration of effective amounts of telmisartan and ramipril; strokes; cardiovascular disorders; organoprotective, tissue-protective, and vasculoprotective effects of combined treatment |
| 06/19/2008 | US20080146630 Estrogen receptor modulators; neurodegenerative disorders; cognitive enhancement |
| 06/19/2008 | US20080146627 Thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives, e.g., butyl 2-(4-[1,1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate inhibit lipidic peroxidation and monoamine oxidase and modulate sodium channels and are used for treating neurodegenerative disorders or pain. |
| 06/19/2008 | US20080146623 Inhibitors of histone deacetylase and prodrugs thereof |
| 06/19/2008 | US20080146613 Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| 06/19/2008 | US20080146609 5-[3-(6,8-Dibromo-1,2,3,4-tetrahydro-quinolin-4-ylamino)-propylamino]-4H-thieno [3,2-b]pyridin-7-one, used as inhibitors of bacterial methionyl tRNA synthetase, administered for the treatment of bacterial infections; therapy for Clostridium difficile based infections |
| 06/19/2008 | US20080146595 Non-nucleoside reverse transcriptase inhibitors |
| 06/19/2008 | US20080146591 Contains non-hygroscopic organic acid as stabilizer; for oral administration, after being constituted in water |
| 06/19/2008 | US20080146575 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one as crystalline; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic with BRCA2 deficient phenotype; septic shock, ischemic injury, multiple sclerosis |
| 06/19/2008 | US20080146573 Preparation and utility of substituted oxzolidinones |
| 06/19/2008 | US20080146566 treatment of diseases mediated by cytokines; N-cyclopropyl-4-methyl-3-(1-oxoisoquinolin-2(1H)-yl)benzamide; rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, inflammatory bowel disease, multiple sclerosis, AIDS, septic shock, congestive heart failure, ischaemic heart disease, psoriasis |
| 06/19/2008 | US20080146564 the major cause of lower respiratory tract illness during infancy and childhood |
| 06/19/2008 | US20080146562 Halogenated quinazolinyl nitrofurans as antibacterial agents |
| 06/19/2008 | US20080146553 Antibiotic compostions and methods for using same |
| 06/19/2008 | US20080146551 Antibacterial Agents |
| 06/19/2008 | US20080146537 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 06/19/2008 | US20080146533 Containing tertiary amine linked pyrrolidine, azetidine, morpholine or piperidine group; inhibiting GlyCer synthase, lowering glycosphingolipid levels; collagen vascular diseases, atherosclerosis, diabetic renal hypertrophy |
| 06/19/2008 | US20080146530 Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 06/19/2008 | US20080146528 stilbene phosphate derivatives; anticarcinogenic agents; bactericide, fungicide; veterinary medicine |
| 06/19/2008 | US20080146527 Antibacterial 1-(4-mono- and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereof |
| 06/19/2008 | US20080146522 Inflammation, allergic diseases, metastatic cancers, pathogen infections; glycosaminoglycan related molecules |
| 06/19/2008 | US20080146517 Indole Antiviral Compositions And Methods |
| 06/19/2008 | US20080146507 Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor |
| 06/19/2008 | US20080146506 Methods of Suppressing Microglial Activation |
| 06/19/2008 | US20080146499 Identification of the Precise Amino Acid Sequence of the Epitope Recognized by the Potent Neutralizing Human Anti-Hiv-1 Monoclonal Antibody Igg1b12 |
| 06/19/2008 | US20080146458 Process for the preparation of oxazolidinones and method of use thereof |
| 06/19/2008 | US20080145866 Modified human thymic stromal lymphopoietin |
| 06/19/2008 | US20080145453 4-(piperimidine-2thione)phenyl derivatives; kinesin Eg5 inhibitor; anticarcinogenic agent; the aldehyde, the ketone and the thiourea are reacted together in the solid phase, grafted onto resin by esterification, and detached by hydrolysis |
| 06/19/2008 | US20080145441 Core of metal atoms of gold, silver or copper covalently linked to a carbohydrate group and to at least 20 ligands |
| 06/19/2008 | US20080145420 Multimeric immunoglobulin for use in prevention and treatment of viral and microorganismal infection |
| 06/19/2008 | US20080145418 Diindolylmethane for the treatment of HPV infection |
| 06/19/2008 | US20080145387 N-(3-aminopropyl)-N,N-dimethyl-2,3-bis(-9-tetradeceneyloxy)-1 -propanaminium salt; cytofectin and lipid mixture |
| 06/19/2008 | US20080145384 stimulating an immune response against a secreted enterohemorragic Escherichia coli (EHEC) antigen; cell culture supernatant is cultured under conditions that favor Type III antigen secretion; prevent infections |
| 06/19/2008 | US20080145381 Multi-subtype FIV vaccines |
| 06/19/2008 | US20080145354 Polyoxyethylene glycol; biocompatability; bioavailability |
| 06/19/2008 | US20080145346 Using modulators of heterogeneous nuclear ribonucleoprotein (hnRNP) K binding as therapeutic in treatment of viral diseases |
| 06/19/2008 | US20080145339 Modified rolling circle initiator protein for use as therapeutic tool in suppression of viral replication and disorders |
| 06/19/2008 | US20080145334 Hepatitis c virus inhibitors |
| 06/19/2008 | US20080145322 picene (benzo[a,i]chrysene) carboxylic acid derivatives; bactericide; with other antimicrobial agent or antibiotic; prostatitis, biliary tract infections, urinary tract infections, cystitis, lung infections, sinus infections, ear infections, acne, rosacea, dental caries, periodontitis |
| 06/19/2008 | US20080145319 Compositions containing Anthocyanosides and/or Procyanidins, Isoquinoline alkaloids extracted from Sanguinaria canadensis, Macleaya cordata or Macleaya microcarpa, and optionally a Zanthoxylum bungeanum and/or Echinacea angustifolia lipophilic extract; for treatment of throat redness and inflammation |
| 06/19/2008 | US20080145317 Comprising 10 to 65 wt % florfenicol, 20 to 80 wt % of an alkaline component, and 0 to 60 wt % of an acid component; capable of effervescence in presence of moisture; rapidly solubilizing additive for addition to drinking water systems for treatment of bacterial infections in animals |
| 06/19/2008 | DE102006059510A1 Beschichtete Pellets Coated pellets |
| 06/19/2008 | DE102006059319A1 Substituierte Aminofuranone und ihre Verwendung Substituted aminofuranones and their use |
| 06/19/2008 | DE102006058209A1 New triterpene type compounds comprising a pentacyclic basic unit of nor-oleanane- or nor-ursane-type, are 11-beta-hydroxysteroid dehydrogenase inhibitors, useful e.g. to treat and prevent diabetes, depression and glaucoma |
| 06/19/2008 | DE102006058207A1 New triterpene type compounds comprising a pentacyclic basic structure of nor-oleanan- or non-ursan -types are 11-beta-hydroxysteroid dehydrogenase inhibitors, useful e.g. to treat and prevent the diabetes, depression and glaucoma |
| 06/19/2008 | CA2672503A1 Substituted aminofuranones and their use |
| 06/19/2008 | CA2672338A1 Archaeal polar lipid aggregates for administration to animals |
| 06/19/2008 | CA2672261A1 Methods for treating cystic fibrosis or pneumonia with bacterial infection via pulmonary administration of fosfomycin |
| 06/19/2008 | CA2672176A1 1-phenyl 1-thio-d-glucitol derivative |
| 06/19/2008 | CA2672026A1 Salmonella vaccine |
| 06/19/2008 | CA2671938A1 Transdermal delivery systems of beta-lactam antibiotics |
| 06/19/2008 | CA2671485A1 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents |
| 06/19/2008 | CA2671478A1 Non-nucleoside reverse transcriptase inhibitors |
| 06/19/2008 | CA2671473A1 Piperidine derivative used for treating chemokine receptor 5 mediated diseases |
| 06/19/2008 | CA2671460A1 Piperidine derivative used for treating chemokine receptor 5 mediated diseases |
| 06/19/2008 | CA2668935A1 Compositions and methods for treating infectious bronchitis |
| 06/19/2008 | CA2668933A1 Methods for treating and reducing the incidence of newcastle disease |
| 06/19/2008 | CA2660038A1 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 06/19/2008 | CA2652995A1 Novel inhibitors of beta-lactamase |